These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 17006931)
21. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Schuldiner O; Benvenisty N Oncogene; 2001 Aug; 20(36):4984-94. PubMed ID: 11526483 [TBL] [Abstract][Full Text] [Related]
22. A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors. Li Z; Zheng W; Wang Z; Zeng Z; Zhan H; Li C; Zhou L; Yan C; Spitsbergen JM; Gong Z Dis Model Mech; 2013 Mar; 6(2):414-23. PubMed ID: 23038063 [TBL] [Abstract][Full Text] [Related]
23. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver. Ella E; Heim D; Stoyanov E; Harari-Steinfeld R; Steinfeld I; Pappo O; Perlman TS; Nachmansson N; Rivkin L; Olam D; Abramovitch R; Wege H; Galun E; Goldenberg D Oncotarget; 2014 Nov; 5(21):10318-31. PubMed ID: 25401338 [TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing. Aravalli RN; Talbot NC; Steer CJ World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234 [TBL] [Abstract][Full Text] [Related]
25. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433 [TBL] [Abstract][Full Text] [Related]
26. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization]. Yang S; Wang M; You W Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):415-7. PubMed ID: 8697990 [TBL] [Abstract][Full Text] [Related]
27. Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma. Lu L; Han H; Tian Y; Li W; Zhang J; Feng M; Li Y Mol Carcinog; 2015 Nov; 54(11):1467-79. PubMed ID: 25284017 [TBL] [Abstract][Full Text] [Related]
28. Disregulation of E-cadherin in transgenic mouse models of liver cancer. Calvisi DF; Ladu S; Conner EA; Factor VM; Thorgeirsson SS Lab Invest; 2004 Sep; 84(9):1137-47. PubMed ID: 15220935 [TBL] [Abstract][Full Text] [Related]
29. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats. Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347 [TBL] [Abstract][Full Text] [Related]
30. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. Frau M; Feo F; Pascale RM J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184 [TBL] [Abstract][Full Text] [Related]
31. Distribution of oval cells and c-myc mRNA expression in mouse hepatocarcinogenesis. Fang CH; Zhang GQ; Zhu XY; Gong JQ Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):433-9. PubMed ID: 15313684 [TBL] [Abstract][Full Text] [Related]
32. Proteomic mining in the dysplastic liver of WHV/c-myc mice--insights and indicators for early hepatocarcinogenesis. Liu Y; Li C; Xing Z; Yuan X; Wu Y; Xu M; Tu K; Li Q; Wu C; Zhao M; Zeng R FEBS J; 2010 Oct; 277(19):4039-53. PubMed ID: 20807235 [TBL] [Abstract][Full Text] [Related]
33. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers. Ikeguchi M; Hirooka Y Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488 [TBL] [Abstract][Full Text] [Related]
34. Use of a rainbow trout oligonucleotide microarray to determine transcriptional patterns in aflatoxin B1-induced hepatocellular carcinoma compared to adjacent liver. Tilton SC; Gerwick LG; Hendricks JD; Rosato CS; Corley-Smith G; Givan SA; Bailey GS; Bayne CJ; Williams DE Toxicol Sci; 2005 Dec; 88(2):319-30. PubMed ID: 16141433 [TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551 [TBL] [Abstract][Full Text] [Related]
36. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945 [TBL] [Abstract][Full Text] [Related]
37. Myc-induced liver tumors in transgenic zebrafish can regress in tp53 null mutation. Sun L; Nguyen AT; Spitsbergen JM; Gong Z PLoS One; 2015; 10(1):e0117249. PubMed ID: 25612309 [TBL] [Abstract][Full Text] [Related]
38. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis. Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672 [TBL] [Abstract][Full Text] [Related]
39. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477 [TBL] [Abstract][Full Text] [Related]
40. E2F1 interactive with BRCA1 pathway induces HCC two different small molecule metabolism or cell cycle regulation via mitochondrion or CD4+T to cytosol. Chen Q; Wang L; Jiang M; Huang J; Jiang Z; Feng H; Ji Z J Cell Physiol; 2018 Feb; 233(2):1213-1221. PubMed ID: 28474358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]